ASHLYN SCHNEIDER: Open Payments
NPI 1750165155 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,359 in 158 payments from 16 companies in 2025. Trend: 2023 $307 · 2024 $1,379 · 2025 $3,359
Food & beverage: $3,160Education: $199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $804 |
| UCB, Inc. | 45 | $666 |
| Janssen Biotech, Inc. | 15 | $610 |
| GENZYME CORPORATION | 11 | $299 |
| Lilly USA, LLC | 10 | $218 |
| Regeneron Healthcare Solutions, Inc. | 9 | $194 |
| Incyte Corporation | 1 | $127 |
| PFIZER INC. | 6 | $119 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Amgen Inc. | 3 | $57 |
Products named: Bimzelx, TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, EBGLYSS, Opzelura, CIBINQO.
Industry payments across LA — which companies pay providers there.
